Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Exchange Rate Effect (2018 - 2025)

Historic Exchange Rate Effect for Sangamo Therapeutics (SGMO) over the last 9 years, with Q3 2025 value amounting to $42000.0.

  • Sangamo Therapeutics' Exchange Rate Effect fell 9627.0% to $42000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 1623.71%. This contributed to the annual value of -$2.0 million for FY2024, which is 23809.84% down from last year.
  • Latest data reveals that Sangamo Therapeutics reported Exchange Rate Effect of $42000.0 as of Q3 2025, which was down 9627.0% from $2.7 million recorded in Q2 2025.
  • Sangamo Therapeutics' Exchange Rate Effect's 5-year high stood at $2.7 million during Q2 2025, with a 5-year trough of -$2.2 million in Q4 2024.
  • Over the past 5 years, Sangamo Therapeutics' median Exchange Rate Effect value was $130000.0 (recorded in 2022), while the average stood at $235631.6.
  • As far as peak fluctuations go, Sangamo Therapeutics' Exchange Rate Effect plummeted by 53307.09% in 2023, and later skyrocketed by 116303.5% in 2025.
  • Sangamo Therapeutics' Exchange Rate Effect (Quarter) stood at -$115000.0 in 2021, then skyrocketed by 773.91% to $775000.0 in 2022, then skyrocketed by 74.58% to $1.4 million in 2023, then crashed by 266.08% to -$2.2 million in 2024, then soared by 101.87% to $42000.0 in 2025.
  • Its Exchange Rate Effect stands at $42000.0 for Q3 2025, versus $2.7 million for Q2 2025 and $1.3 million for Q1 2025.